FORESITE CAPITAL MANAGEMENT IV, LLC
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | PHVS | 4.78M | $134.99M |
 | ALEC | 3.89M | $8.36M |
 | RLAY | 1.00M | $9.95M |
 | LYEL | 800K | $16.06M |
 | CYTK | 503K | $33.17M |
 | XENE | 160K | $9.30M |
 | MAZE | 157K | $4.68M |
Pharvaris N.V.
PHVS
Shares Held
4.78M
Value
$134.99M
Alector, Inc.
ALEC
Shares Held
3.89M
Value
$8.36M
Relay Therapeutics, Inc.
RLAY
Shares Held
1.00M
Value
$9.95M
Lyell Immunopharma, Inc.
LYEL
Shares Held
800K
Value
$16.06M
Cytokinetics, Incorporated
CYTK
Shares Held
503K
Value
$33.17M
Xenon Pharmaceuticals Inc.
XENE
Shares Held
160K
Value
$9.30M
Maze Therapeutics, Inc.
MAZE
Shares Held
157K
Value
$4.68M